109 filings
Page 2 of 6
8-K
s2gdm26
18 Apr 23
Regulation FD Disclosure
8:00am
8-K
zbq1kq
15 Mar 23
Matinas BioPharma Reports 2022 Financial Results and Provides a Business Update
4:05pm
8-K
eljf91y2n5i3sr7ypnlo
30 Jan 23
Matinas BioPharma Provides Business Update and 2023 Strategic Outlook
4:00pm
8-K
l1kx6qk ehvk5t
12 Jan 23
Regulation FD Disclosure
6:59am
8-K
vv550 1e94
29 Dec 22
Regulation FD Disclosure
7:00am
8-K
flof2r319va2gzd1 pri
14 Nov 22
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
cfg9x2p
2 Nov 22
Matinas BioPharma Reports Third Quarter 2022 Financial Results and Highlights Recent Progress
4:05pm
8-K
5b2arhr
21 Oct 22
Matinas BioPharma Announces Positive Interim Data from the Phase 2
7:00am
8-K
xjwu04xrxq0zxb40y
13 Sep 22
Regulation FD Disclosure
7:00am
8-K
eb9dwj
11 Aug 22
Matinas BioPharma Reports Second Quarter 2022 Financial Results and Highlights Recent Progress
6:25am
8-K
wl2udt 3z
12 May 22
Matinas BioPharma Reports First Quarter 2022 Financial Results and Operational Highlights
6:30am
8-K
pvnrg5iw8le
13 Apr 22
Regulation FD Disclosure
8:43am
8-K
swl6erb 92h89lf36y
11 Apr 22
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based Vaccines
7:00am
8-K
6nd3pske bn0csnoa7o0
8 Mar 22
Matinas BioPharma Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Highlights
6:30am
8-K
p3drok7
25 Jan 22
Matinas BioPharma Provides Business Update and 2022 Strategic Outlook
6:30am
8-K
0nau46yd33vcr
16 Dec 21
Regulation FD Disclosure
6:30am
8-K
q12zttnphv8fyjc
6 Dec 21
Matinas BioPharma Appoints Thomas Hoover, M.B.A. as Chief Business Officer
6:30am
8-K
hijhcqwbxky5
8 Nov 21
Matinas BioPharma Reports Third Quarter 2021 Financial Results and Operational Highlights
6:35am
8-K
lkz0ax4viwnc8fw
1 Nov 21
Submission of Matters to a Vote of Security Holders
5:15pm
8-K
fsfl ifa61xr75
20 Sep 21
Matinas BioPharma Announces Accomplished Biotechnology Executive and Drug Developer Kathryn Penkus Corzo as Nominee to the Board of Directors
7:05am